Description
ARA-290 (Cibinetide) is a helix-B surface peptide (HBSP) derived from erythropoietin (EPO) that selectively activates the innate repair receptor (IRR; EPO receptor/β common receptor heterodimer) without triggering the erythropoietic pathway. It is studied for neuroprotective, anti-inflammatory, and tissue-repair effects in preclinical models—particularly in peripheral neuropathy and ischaemic injury research.
Available as 10 mg lyophilized at ≥98% purity with COA.
| Format | Lyophilized powder |
|---|---|
| Purity | ≥98% HPLC |
| CAS | 1355814-82-0 |
Research Use Only. Not for human or veterinary use.
